Sanara MedTech Inc. (SMTI)
Largest Insider Buys in Sector
SMTI Stock Price History Chart
SMTI Stock Performance
About Sanara MedTech Inc.
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako's Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps …
Insider Activity of Sanara MedTech Inc.
Over the last 12 months, insiders at Sanara MedTech Inc. have bought $0 and sold $0 worth of Sanara MedTech Inc. stock.
On average, over the past 5 years, insiders at Sanara MedTech Inc. have bought $0 and sold $124,297 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,927,712 shares for transaction amount of $16M was made by Nixon Ronald T () on 2019‑10‑15.
List of Insider Buy and Sell Transactions, Sanara MedTech Inc.
| 2022-11-08 | Sale | Chief Executive Officer | 417 0.0053% | $33.00 | $13,761 | +19.97% | ||
| 2022-11-04 | Sale | Chief Executive Officer | 563 0.0071% | $33.00 | $18,579 | +20.33% | ||
| 2022-11-02 | Sale | Chief Executive Officer | 20 0.0003% | $33.02 | $660 | +32.08% | ||
| 2022-09-22 | Sale | Pres. - Strategic Partnerships | 1,000 0.0117% | $27.89 | $27,887 | +34.55% | ||
| 2022-07-05 | Sale | Chief Executive Officer | 750 0.0099% | $23.00 | $17,250 | +76.24% | ||
| 2022-06-28 | Sale | Chief Executive Officer | 294 0.0039% | $21.00 | $6,174 | +82.69% | ||
| 2022-06-24 | Sale | Chief Executive Officer | 457 0.0059% | $21.00 | $9,597 | +77.16% | ||
| 2022-06-17 | Sale | Pres. - Strategic Partnerships | 1,000 0.013% | $20.02 | $20,020 | +86.86% | ||
| 2021-10-26 | Sale | President - Surgical Div. | 1,000 0.0128% | $34.04 | $34,040 | -24.58% | ||
| 2021-10-20 | Sale | President - Wound Care Div. | 1,000 0.0133% | $34.19 | $34,191 | -21.82% | ||
| 2021-10-05 | Sale | President - Surgical Div. | 1,000 0.0128% | $33.10 | $33,104 | -22.17% | ||
| 2021-09-28 | Sale | President - Wound Care Div. | 1,000 0.0131% | $33.33 | $33,330 | -20.62% | ||
| 2019-10-15 | 1.93M 25.6795% | $8.30 | $16M | +50.00% | ||||
| 2019-10-15 | 361,446 4.8149% | $8.30 | $3M | +50.00% | ||||
| 2019-10-15 | 120,482 1.605% | $8.30 | $1M | +50.00% | ||||
| 2015-07-31 | 1,786 1.2257% | $69.99 | $125,000 | -30.00% | ||||
| 2015-07-31 | 1,786 – | $69.99 | $125,000 | -30.00% | ||||
| 2013-12-19 | director | 1,723 – | $0 | $0 | +11.11% | |||
| 2013-11-12 | CEO | 3,257 – | $0 | $0 | +42.86% | |||
| 2012-12-23 | Sale | director | 8,877 0.7705% | $3.00 | $26,631 |
Insider Historical Profitability
| COSSUTTA ARALDO A | director | 5259214 60.1661% | $33.68 | 2 | 5 | |
| HAIRE SCOTT A | President & CEO | 4646403 53.1555% | $33.68 | 2 | 0 | |
| EVANS STEVE W | 1348333 15.4251% | $33.68 | 1 | 0 | ||
| Nixon Ronald T | 963856 11.0266% | $33.68 | 1 | 0 | +50% | |
| STUCKERT JAMES W | 814830 9.3218% | $33.68 | 2 | 0 | +50% |
Institutional Investor Ownership
| BlackRock | $90.46M | 104.88 | 9.05M | +4,318.25% | +$88.41M | <0.01 | |
| State Street | $63.7M | 73.86 | 6.37M | +11,829.37% | +$63.17M | <0.01 | |
| Geode Capital Management | $24.17M | 28.02 | 2.42M | +7.22% | +$1.63M | <0.01 | |
| Boxer Capital, LLC | $15.45M | 17.91 | 1.54M | New | +$15.45M | 0.32 | |
| Duquesne Family Office Llc | $9.84M | 11.41 | 984,000 | New | +$9.84M | 0.27 |